Literature DB >> 8421154

Diaphragm disease of the ascending colon. Association with sustained-release diclofenac.

F Halter1, B Weber, T Huber, F Eigenmann, M P Frey, C Ruchti.   

Abstract

We describe the clinicopathological features of six patients, two with rheumatoid arthritis and four with osteoarthritis, in whom intake of sustained-release diclofenac for one or more years was associated with ulceration and or stricture of the ascending colon. All were referred for further evaluation of anemia and changes in bowel habits. Three had chronic watery diarrhea, one suffered from progressive constipation and subsequently needed a right hemicolectomy because of complete intestinal obstruction. In five patients, colonoscopy revealed single to multiple semilunar ulcers, predominantly localized on the crest of the haustra of the ascending colon. In five of six cases the lumen was narrowed, from slight accentuation of the haustrum to almost pinhole-like concentric stenosis. All except one patient had multiple diaphragm-like strictures. The macroscopic and microscopic appearances closely resembled those of similar lesions previously described in the terminal ileum in patients treated with nonsteroidal anti-inflammatory drugs. It appears that the slow-release form of a nonsteroidal anti-inflammatory drug, such as sustained-release diclofenac, predisposes to manifestations of such lesions in the ascending colon.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421154     DOI: 10.1097/00004836-199301000-00020

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  16 in total

1.  Abdominal mass in a woman taking non-steroidal anti-inflammatory drugs.

Authors:  S R Preston; C Lough; A J Shakeshaft; P J Guillou
Journal:  J R Soc Med       Date:  1999-06       Impact factor: 5.344

2.  Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.

Authors:  H P Haber; N Benda; G Fitzke; A Lang; M Langenberg; J Riethmüller; M Stern
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 3.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

4.  [NSAID-colonopathy].

Authors:  M Vieth
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

5.  Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.

Authors:  Dorsey M Bass; Mary Prevo; Deborah S Waxman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Strictures, diaphragms, erosions or ulcerations of ischemic type in the colon should always prompt consideration of nonsteroidal anti-inflammatory drug-induced lesions.

Authors:  Manfred Stolte; Diana Karimi; Michael Vieth; Hildegard Volkholz; Klaus Dirschmid; Sigrid Rappel; Birgit Bethke
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

7.  Non-steroidal anti-inflammatory drug-induced jejunal and colonic diaphragm disease.

Authors:  F Halter; T H Huber; C H Ruchti
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

Review 8.  Nonsteroidal antiinflammatory drug-induced colonic stricture. An unusual cause of large bowel obstruction and perforation.

Authors:  M H Robinson; T Wheatley; I H Leach
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

9.  Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?

Authors:  W E Roediger; S Millard
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

10.  Dependency of gastrointestinal toxicity on release rate of tiaprofenic acid: a novel pharmacokinetic-pharmacodynamic model.

Authors:  M Vakily; F Khorasheh; F Jamali
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.